JNCI Journal of the National Cancer Institute · 1976 · 48 citations · 0 references
MedicineOncologyPharmacologyChemotherapyMetastasisPediatric OncologyCentral Nervous System Tumor PharmacotherapyMetastatic Disease TreatmentPediatric ChemotherapyPediatric Neuro-oncologyCell Culture ConditionsCell Culture KineticsCell Growth RegulationClinical Program EvaluationDose Range AssessmentExperimental StudiesNeuroblastoma BiologyTherapeutic Dose Range
In developing a chemotherapeutic program for children with disseminated neuroblastoma, we established three human neuroblastoma lines in cell culture to study the effects of dibutyryl cyclic AMP, papaverine, 5-trifluoromethyl-2'-deoxyuridine, and cyclophosphamide on cell growth, biochemical behavior, and morphology. Based upon our studies, a clinical treatment program was designed. We have treated 15 patients with disseminated neuroblastoma and have established the optimum dose range and sequence of these drugs. Early results were promising; plans for continuation of clinical and experimental studies were discussed.